Vanda Pharmaceuticals, Inc. (VNDA)
Vanda Pharmaceuticals Market Cap: 358.72M for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.549B |
| ADMA Biologics, Inc. | 4.712B |
| Aldeyra Therapeutics, Inc. | 287.28M |
| Exelixis, Inc. | 11.22B |
| Anavex Life Sciences Corp. | 394.47M |
Market Cap Related Metrics
| PS Ratio | 1.681 |
| PEG Ratio | -0.0104 |
| Price to Book Value | 0.7698 |
| Price | 6.07 |
| Earnings Yield | -23.58% |
| PEGY Ratio | -0.0104 |